CIBC World Market
GHDX

CIBC World Market’s Genomic Health, Inc. GHDX Stock Holding History

CIBC World Market’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-22,235
Closed -$1.56M – 1272
2019
Q1 		$1.56M Sell
22,235
-3,049
-12% -$226K 0.01% 554
2018
Q4 		$1.63M Buy
+25,284
New +$1.77M 0.01% 496

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CIBC World Market's GHDX Position: Q2 2019 in Review

CIBC World Market sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 22,235 shares — an estimated $1.56M sold.

CIBC World Market first reported a position in GHDX in Q4 2018 and held it in 2 quarters. The position peaked at $1.63M in Q4 2018. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

  • CIBC World Market reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
  • CIBC World Market sold 22,235 Genomic Health, Inc. shares in Q2 2019, an estimated $1.56M.
  • CIBC World Market first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 2 quarters.
  • CIBC World Market's Genomic Health, Inc. position peaked at $1.63M in Q4 2018.
  • 215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on CIBC World Market's 13F filing for Q2 2019, filed 8 Aug 2019.